Day 3 - 2023 agenda. The 2024 agenda will be published soon. - CET/CEST (Cent Europe Summer, GMT+2)
Day 3 - 2023 agenda. The 2024 agenda will be published soon. - CET/CEST (Cent Europe Summer, GMT+2)
Location: Room Stockholm
- Linda Pullan - Founder, Pullan Consulting
- Patrick Tricoli - CEO Nanobiotix US , Head of Business Development, Nanobiotix
- Joe Lawson - Senior Director, Johnson & Johnson
Location: Room Stockholm
This exclusive media round-up brings together a comprehensive recap of BIO-Europe 2023. Capture the pulse of the event by diving into the highlights, fresh perspectives, key insights, and impactful takeaways shared by speakers and participants, until we welcome you again at BIO-Europe 2024, in Stockholm!
- Catherine Featherston - Media & Communications Consultant, MC Services AG
- Kevin Grogan - Managing Editor, Europe, Scrip
- Georg Kääb - Managing Editor, transkript / Biocom GmbH
- Mike Ward - Global Head of Thought Leadership, Decision Resources Group, part of Clarivate
Location: Room Barcelona
9:45 – 10:00 Doron Therapeutics Pain Management
10:00 – 10:15 AATec Medical GmbH Immunology
10:15 - 10:30 Phaim Pharma Immunology
Location: Room Barcelona
10:30 – 10:45 Shanghai Mabgeek Biotech Co., Ltd. Dermatology
10:45 – 11:00 eleva GmbH Technology and Drug Development
11:00 – 11:15 SiSaf Ltd Rare & Orphan Diseases
11:15 – 11:30 Progeneer Inc. Vaccines
11:45 – 12:00 Endogena Therapeutics Inc. Respiratory
Location: Room San Sebastian
9:30 – 9:45 MOLCURE Inc. Antibodies
9:45 – 10:00 Multitude Therapeutics Antibodies
10:00 – 10:15 Tiziana Life Sciences Antibodies
10:15 – 10:30 Lumos Pharma Inc Rare and Orphan Diseases
Location: Room San Sebastian
10:30 – 10:45 Amyl Therapeutics CNS/Neurology
10:45 – 11:00 OrganoTherapeutics CNS/Neurology
11:00 – 11:15 Kiji Therapeutics Autoimmune/Inflammation
11:15 – 11:30 Tonix Pharmaceuticals Holding Corp. CNS/Neurology
11:30 – 11:45 InflaRx N.V. Autoimmune/Inflammation
11:45 – 12:00 Acadia Pharmaceuticals Inc. CNS/Neurology
Location: Exhibit Hall Stage
In the dynamic landscape of mid-stage startups, efficient management of cash flow is a critical factor for survival and growth. In this session, EVERSANA's Rohit Sood will be joined by Shorla Oncology's CEO, Sharon Cunningham, to delve deep into the world of optimizing investments to manage cash flow and collaborative approaches to empower these innovators.
This engaging discussion will explore the collaborative strategies and innovative approaches that mid-stage startups can employ to optimize cash management. Key topics to be addressed include:
- The Cash Crunch Dilemma: Understanding the vital considerations like resource allocation and the financial challenges faced by mid-stage startups
- Collaboration as a Growth Catalyst: How strategic partnerships can optimize cash flow and resource allocation
- Navigating Risk: Risk assessment and management strategies to navigate the uncertainties of the business environment
- Case Studies and Best Practices: Real-world examples of successful cash management strategies, including those experienced by Shorla Oncology
Join us for this conversation, where Rohit Sood and Sharon Cunningham will uncover the collaborative solutions that will shape the future of life sciences finance.
- Rohit Sood - Executive VP, EVERSANA COMPLETE Commercialization®
- Sharon Cunningham - CEO & Co-Founder, Shorla Oncology
Location: Exhibit Hall Stage
Japan’s biotech ecosystems are flourishing with numerous opportunities for collaboration. Representative from JETRO Bruxelles ,Japan Machinery Center for Trade and Investment Brussels Office will present an overview of the new government policy and initiatives to accelerate biotech innovation in Japan. Moreover, case studies of companies, representing Japanese Bioindustry will be presented.
- Taku Sato - Director in charge of Healthcare industry, Overseas Business Development Department, Japan External Trade Organization (JETRO)
- Kozo Saiki - Director General, Japan Machinery Center for Trade and Investment Brussels Office
- Akihiro Imura - CEO, COGNANO Inc.
- Satoshi Tamaki - CSO, MOLCURE Inc.
- Kajikawa Masunori - President and CEO, Rebirthel Co., Ltd.
- Reina Kodera - Deputy Director, Bio-Industry Division, Commerce and Service Industry Policy Group, METI
Location: Exhibit Hall Stage
Learn everything you need to know to power up your partnering! This session is for delegates familiar with partnering who want to take their partnering practice to the next level. This session will go over specific tools and top tips for collaborating with colleagues, saving time, as well as increasing response rates and acceptance rates. Come away from the session with a clear understanding of how partneringONE can support your company to maximize ROI from partnering, at this and future events.
Location: Exhibit Hall Stage
Experience how a few breaths and stretches can de-stress you in just a few minutes.
Take a moment to exhale and move your body.
Calm your mind and feel the difference.
These sessions are designed to refresh your body and mind so you can get through a full conference day with more ease.
Open to all, without prerequisites.
Standing and seated (chair) exercises only.
Location: Room Barcelona
12:00 – 12:15 Synaffix BV Technologies & Tools
Location: Room San Sebastian
12:00 – 12:15 GBIOLOGICS Inc. Autoimmune/Inflammation
Location: Exhibit Hall Stage
Learn everything you need to know to power up your partnering! This session is for delegates new to partnering. In this workshop, we will go over what you can expect out of partnering and what others will expect from you. We will provide an overview of the platform and discuss principles around timing and best practices to get the most out of partneringONE. Come away from the session with a clear understanding of what you can do to generate the best return on investment from partnering, at this and future events.